Useful Contacts

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The proposed $700 million, 700,000-square-foot space will support the companies’ future joint portfolio of next-generation obesity medicines.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Poor API quality may often lead to delays in production and a shortage of supply.

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with the current standard of care, according to a phase III trial.